Related references
Note: Only part of the references are listed.Introducing a pyrazolopyrimidine as a multi-tyrosine kinase inhibitor, using multi-QSAR and docking methods
Asrin Bahmani et al.
MOLECULAR DIVERSITY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Safety and efficacy of Prunella vulgaris preparation in adjuvant treatment of thyroid nodules A meta-analysis
Qing Han et al.
MEDICINE (2021)
Platelet-Derived Growth Factor Receptor-α Subunit Targeting Suppresses Metastasis in Advanced Thyroid Cancer In Vitro and In Vivo
Ching-Ling Lin et al.
BIOMOLECULES & THERAPEUTICS (2021)
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution
Tommaso Porcelli et al.
ENDOCRINE (2021)
Cancer statistics for adolescents and young adults, 2020
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
Jierui Liu et al.
ENDOCRINOLOGY AND METABOLISM (2019)
Dose- and time-dependent pharmacokinetics of apigenin trimethyl ether
Mai Gamal Elhennawy et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A phase I study of pazopanib in combination with escalating doses of 131 I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine
Laura Q. Chow et al.
PLOS ONE (2017)
Generation of Novel Thyroid Cancer Stem-Like Cell Clones Effects of Resveratrol and Valproic Acid
Heather Hardin et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine
James Nagarajah et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Discovery of polymethoxyflavones from black ginger (Kaempferia parviflora) as potential beta-secretase (BACE1) inhibitors
Kumju Youn et al.
JOURNAL OF FUNCTIONAL FOODS (2016)
PDGFRα Regulates Follicular Cell Differentiation Driving Treatment Resistance and Disease Recurrence in Papillary Thyroid Cancer
Ana Lopez-Campistrous et al.
EBIOMEDICINE (2016)
Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1
Yujiro Hayashi et al.
GASTROENTEROLOGY (2015)
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Martin Schlumberger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Anti-allergenic activity of polymethoxyflavones from Kaempferia parviflora
Shoko Kobayashi et al.
JOURNAL OF FUNCTIONAL FOODS (2015)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose et al.
LANCET (2014)
The O-methylation of chrysin markedly improves its intestinal anti-inflammatory properties: Structure-activity relationships of flavones
Alexandrine During et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth
Xiao-Min Yu et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
Clinical, Safety, and Economic Evidence in Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Systematic Literature Review
Roger T. Anderson et al.
THYROID (2013)
Structural and Functional Properties of Platelet-Derived Growth Factor and Stem Cell Factor Receptors
Carl-Henrik Heldin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Modulation of sodium iodide symporter expression and function by LY294002, Akti-1/2 and Rapamycin in thyroid cells
Yu-Yu Liu et al.
ENDOCRINE-RELATED CANCER (2012)
Pharmacokinetics, Bioavailability, Tissue Distribution, Excretion, and Metabolite Identification of Methoxyflavones in Kaempferia parviflora Extract in Rats
Catheleeya Mekjaruskul et al.
DRUG METABOLISM AND DISPOSITION (2012)
Analysis of multiple compound-protein interactions reveals novel bioactive molecules
Hiroaki Yabuuchi et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Vasorelaxant Effects of 5,7,4’-Trimethoxyflavone from Kaepmferia parviflora in the Rat Aorta
P. Tep-areena et al.
International Journal of Pharmacology (2010)
Synthesis and Preliminary Biological Evaluation of Chrysin Derivatives as Potential Anticancer Drugs
Xing Zheng et al.
MEDICINAL CHEMISTRY (2010)
Medicinal Chemistry and the Molecular Operating Environment (MOE): Application of QSAR and Molecular Docking to Drug Discovery
Santiago Vilar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells
Takahiko Kogai et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Docking and scoring in virtual screening for drug discovery: Methods and applications
DB Kitchen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulin
KM van Tol et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Random forest: A classification and regression tool for compound classification and QSAR modeling
V Svetnik et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2003)
Src family kinases negatively regulate platelet-derived growth factor α receptor-dependent signaling and disease progression
S Rosenkranz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
